TG THERAPEUTICS INC (TGTX) Stock Analyst Earnings Estimates
NASDAQ:TGTX - Nasdaq - US88322Q1085 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.69M 4,360.00% | 2.79M -58.30% | 233.662M 8,274.98% | 336.75M 44.12% | 561.97M 66.88% | 778.33M 38.50% | 1.125B 44.54% | 1.412B 25.51% | 1.642B 16.29% | 1.784B 8.65% | 2.083B 16.76% | 2.315B 11.14% | |
| EBITDA YoY % growth | -344.49M -25.99% | -192.54M 44.11% | 20.844M 110.83% | 72.471M 247.68% | 182.82M 152.27% | 212.16M 16.05% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -344.77M -26.02% | -192.84M 44.07% | 20.633M 110.70% | 28.291M 37.12% | 190.18M 572.23% | 344.8M 81.30% | 594.86M 72.52% | 828.21M 39.23% | 1.01B 21.95% | 1.096B 8.51% | 1.405B 28.19% | 1.577B 12.24% | |
| Operating Margin | -5,153.51% | -6,911.83% | 8.83% | 8.40% | 33.84% | 44.30% | 52.88% | 58.66% | 61.51% | 61.43% | 67.45% | 68.12% | |
| EPS YoY % growth | -2.63 -15.86% | -1.46 44.49% | 0.01 100.68% | 0.15 1,366.25% | 0.98 570.43% | 2.01 104.76% | 2.64 31.00% | 3.48 31.91% | 4.24 21.99% | 3.98 -6.25% | 5.76 44.87% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.09 188.99% | 0.13 283.02% | 0.19 377.36% | 0.25 1,128.08% | 0.33 267.34% |
| Revenue Q2Q % growth | 100.76M 129.15% | 113.04M 78.09% | 129.85M 76.75% | 145.37M 73.31% | 175.95M 74.62% |
| EBITDA Q2Q % growth | 23.46M 291.14% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 16.92M 235.52% | 30.008M 423.71% | 42.744M 384.85% | 55.897M 349.55% | 82.484M 387.49% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.02 -97.26% | 0.03 | -0.01 | -33.53% |
| Q2 2024 Q2Q % growth | 0.04 111.76% | -0.05 | 0.09 | 185.79% |
| Q1 2024 Q2Q % growth | -0.07 75.00% | -0.04 | -0.03 | -92.18% |
| Q4 2023 Q2Q % growth | -0.10 74.36% | -0.11 | 0.01 | 5.99% |
| Q3 2023 Q2Q % growth | 0.73 380.77% | 0.12 | 0.61 | 518.52% |
| Q2 2023 Q2Q % growth | -0.34 -13.33% | -0.25 | -0.09 | -34.00% |
| Q1 2023 Q2Q % growth | -0.28 45.10% | -0.37 | 0.09 | 25.23% |
| Q4 2022 Q2Q % growth | -0.39 44.29% | -0.27 | -0.12 | -47.06% |
| Q3 2022 Q2Q % growth | -0.26 60.00% | -0.35 | 0.09 | 25.34% |
| Q2 2022 Q2Q % growth | -0.30 49.15% | -0.52 | 0.22 | 42.33% |
| Q1 2022 Q2Q % growth | -0.51 26.09% | -0.61 | 0.10 | 15.87% |
| Q4 2021 Q2Q % growth | -0.70 1.41% | -0.65 | -0.05 | -8.44% |
| Q3 2021 Q2Q % growth | -0.65 -6.56% | -0.57 | -0.08 | -13.22% |
| Q2 2021 Q2Q % growth | -0.59 -25.53% | -0.51 | -0.08 | -15.30% |
| Q1 2021 Q2Q % growth | -0.69 -43.75% | -0.50 | -0.19 | -38.06% |
| Q4 2020 Q2Q % growth | -0.71 -61.36% | -0.59 | -0.12 | -19.67% |
| Q3 2020 Q2Q % growth | -0.61 11.59% | -0.42 | -0.19 | -44.69% |
| Q2 2020 Q2Q % growth | -0.47 -11.90% | -0.34 | -0.13 | -36.33% |
| Q1 2020 Q2Q % growth | -0.48 -11.63% | -0.37 | -0.11 | -31.45% |
| Q4 2019 Q2Q % growth | -0.44 | -0.47 | 0.03 | 5.81% |
| Q3 2019 Q2Q % growth | -0.69 | -0.34 | -0.35 | -100.44% |
| Q2 2019 Q2Q % growth | -0.42 | -0.41 | -0.01 | -1.25% |
| Q1 2019 Q2Q % growth | -0.43 | -0.44 | 0.01 | 3.09% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 83.879M -49.41% | 83.34M | 539K | 0.65% |
| Q2 2024 Q2Q % growth | 73.466M 357.05% | 67.21M | 6.256M | 9.31% |
| Q1 2024 Q2Q % growth | 63.474M 713.46% | 55.7M | 7.774M | 13.96% |
| Q4 2023 Q2Q % growth | 43.971M 43,871.00% | 40.865M | 3.106M | 7.60% |
| Q3 2023 Q2Q % growth | 165.815M 165,715.00% | 47.492M | 118.323M | 249.14% |
| Q2 2023 Q2Q % growth | 16.074M 2,579.00% | 17.802M | -1.728M | -9.71% |
| Q1 2023 Q2Q % growth | 7.803M 290.15% | 3.447M | 4.356M | 126.37% |
| Q4 2022 Q2Q % growth | 100K -95.65% | 1.864M | -1.764M | -94.64% |
| Q3 2022 Q2Q % growth | 100K -95.00% | 1.726M | -1.626M | -94.21% |
| Q2 2022 Q2Q % growth | 600K -60.00% | 202.643K | 397.357K | 196.09% |
| Q1 2022 Q2Q % growth | 2M 150.00% | 2.117M | -117K | -5.53% |
| Q4 2021 Q2Q % growth | 2.3M | 2.281M | 19K | 0.83% |
| Q3 2021 Q2Q % growth | 2M | 3.027M | -1.027M | -33.93% |
| Q2 2021 Q2Q % growth | 1.5M | 3.559M | -2.059M | -57.85% |
| Q1 2021 Q2Q % growth | 800K | 659.603K | 140.397K | 21.29% |
| Q4 2020 Q2Q % growth | 19.38K | -19.38K | -100.00% | |
| Q3 2020 Q2Q % growth | 19.38K | -19.38K | -100.00% | |
| Q2 2020 Q2Q % growth | 29.07K | -29.07K | -100.00% | |
| Q1 2020 Q2Q % growth | 23.256K | -23.256K | -100.00% | |
| Q4 2019 Q2Q % growth | 23.256K | -23.256K | -100.00% | |
| Q3 2019 Q2Q % growth | 27.285K | -27.285K | -100.00% | |
| Q2 2019 Q2Q % growth | 19.38K | -19.38K | -100.00% | |
| Q1 2019 Q2Q % growth | 23.256K | -23.256K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 1521.01% | 0% | -2.54% |
| Revenue | 0% | 27.49% | 0% | 0.54% |